A New Class of Human Data Trials

Organs donated for research and revived with perfusion technology enable a new class of Human Data Trials that can integrate every source of human data to answer questions that are impossible with current Phase I/II clinical trials or preclinical models.

Executive team

Greg Tietjen, PhD

Greg Tietjen, PhD

Co-Founder & Chief Executive Officer

Former Assistant Professor at Yale; pioneer of human organ research

Kourosh Saeb-Parsy,  MD/PhD

Kourosh Saeb-Parsy,  MD/PhD

Co-Founder & Chief Medical Officer

Professor of Transplantation, Transplant Surgeon at the University of Cambridge, UK

Brian Wilcove

Brian Wilcove

Managing Partner at America’s Frontier Fund, with 20+ years of tech investment experience

Ben Yu

Ben Yu

Deep-tech investor, engineer by training, and entrepreneur, focused on backing breakthrough technologies and the future of industrial automation

Jenna DiRito, PhD

Jenna DiRito, PhD

Co-Founder & Chief Operating Officer

World leading expert in human organ research operations

Roger Ferguson

Roger Ferguson

Harvard-trained economist and former Vice Chair of the Fed and CEO of TIAA

Peter Buniak, MBA

Peter Buniak, MBA

Co-Founder

Life sciences CIO and CTO, 20 years of technology architecture development

Helen Hughes

Helen Hughes

Co-Founder & Chief People Officer

Former Senior Executive at Amazon, 20 years creating high performance teams in rapid growth organizations

Janeta Nikolovski, PhD

Janeta Nikolovski, PhD

Chief Data Innovation Officer

Formerly with Johnson & Johnson, 25 yrs Research & Product Development across Pharma, Biotech, Med Device, Digital and Consumer Products

Milad Alucozai, PhD

Milad Alucozai, PhD

Co-Founder

General Partner at Pamir Ventures, neuroscientist, founder, and venture capitalist.

Investors

Bridge the gap between biology and breakthrough

Ready to accelerate your next program?

Schedule a Meeting